Origin, Inc

Origin is a privately-held, clinical-stage biotechnology company founded in June 2010 to develop and commercialize a novel, patented medical technology - delivering therapeutic molecules generated right at the point of care. Our technology is based on Nobel prize-winning research and is designed to surpass current standards of care in efficacy, side effects, and/or cost-effectiveness across a wide range of indications. Plasma medicine is an innovative and emerging field combining plasma physics, life sciences and clinical medicine to use plasma for therapeutic applications. It is the subject of advanced study at major academic institutions in the United States, Russia, Germany, Japan, the United Kingdom, France and Italy.